MedX Health Partners with Skinobs to Bring SkinSecure’s Objective Skin Measurement to Global Cosmetic Research Teams

SkinSecure™ joins the global Skinobs testing directory, making non-invasive measurement of collagen, melanin, and hemoglobin more accessible to CROs, testing laboratories and cosmetic R&D teams. 

MISSISSAUGA, Ontario – September 29 – Finding the right testing methodology is an important part of designing stronger cosmetic research. A new partnership between MedX Health Corp. and Skinobs is making objective, non-invasive skin measurement easier to discover. 

SkinSecure, MedX Health’s cloud-based skin intelligence platform, is now featured on Skinobs, a global platform used by cosmetic R&D teams, formulators, testing laboratories and regulatory professionals to identify testing methods, devices and CRO partners. 

The addition puts SkinSecure in front of researchers at a critical point in the study-planning process: when they are evaluating how to measure product efficacy and substantiate results. 

“Skinobs has built an important global resource for the cosmetic research community, and we see tremendous opportunity in bringing SkinSecure into that ecosystem,” said John Gevisser, CEO of MedX Health. “This partnership puts our technology in front of researchers at the moment they are actively evaluating how to measure product efficacy and gives us a platform to build greater awareness of what objective, non-invasive skin measurement can add to their work. We’re looking forward to what we can build together.” 

Looking beneath the surface 

SkinSecure is built on MedX’s proprietary SIAscopy®, which is a multispectral imaging technology proven to analyze how light interacts with the skin to quantify the concentration and spatial distribution of key chromophores.With this, SkinSecure™ provides non-invasive measurement of collagen, melanin, and hemoglobin up to 2mm beneath the skin’s surface, a key differentiator in today’s market. 

Rather than relying solely on what can be visually observed, researchers can add structured biomarker data to their existing methodologies and follow biological changes longitudinally across study visits. 

For cosmetic R&D teams studying increasingly sophisticated formulations, treatments and claims, that creates another way to investigate a fundamental question: What is changing within the skin? 

Making better measurement easier to find 

Skinobs helps cosmetic researchers navigate a testing landscape that includes hundreds of methods, instruments and service providers. Its platform gives teams a centralized resource for identifying approaches that align with their research objectives. 

Adding SkinSecure to that ecosystem introduces MedX’s technology to researchers actively evaluating testing options for upcoming studies. 

The partnership also reflects a broader evolution in cosmetic research. As brands seek stronger evidence to support product efficacy, interest is growing in objective biological endpoints and methods that can measure change repeatedly without disrupting the tissue being studied. 

“Beauty research is moving toward a deeper understanding of what is changing within the skin,” said Gevisser. “As formulations and claims become more sophisticated, researchers need ways to measure biological change objectively and follow it over time. We believe that shift creates an important opportunity for SkinSecure™ and for MedX to help shape how the next generation of skin research is measured.” 

Find MedX on Skinobs. 

About MedX Health 

MedX Health Corp. (TSXV: MDX) is a data-driven skin health analytics business underpinned by proprietary intellectual property and regulated medical technologies. MedX operates as an ISO 13485-certified medical device manufacturer with regulatory clearance across 38 territories including the U.S., U.K., EU, Australia, and New Zealand. The Company’s platform supports clinical research, aesthetics, and population health applications. MedXalso operates DermSecure™, an FDA-approved teledermatology platform for triage of suspicious skin lesions. 

Media contact: Cheryl Jacobs Rebacz Cheryl.Rebacz@medxhealth.comMedX Health Corp., Mississauga, Ontario | TSXV: MDX | medxhealth.com